公司资料

Cara Therapeutics 股价、新闻与催化剂

股票代码:: CARA
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股价为何变动

Current closing-price context is not available for CARA.

公司概览

业务概览

Cara Therapeutics is a specialty pharmaceutical company with a history in pain and pruritus and a current story shaped by pipeline and commercial reset. The company has had to redefine its growth path.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Cara sits in specialty biopharma.

商业模式特征

The business depends on product execution, strategic repositioning, and the ability to build a more durable portfolio.

生物医药行业定位

Cara is a turnaround-sensitive specialty-pharma name with limited tolerance for disappointment.

未来催化剂

Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture. The company is mainly in a reset / repositioning phase now.